期刊文献+

截短型rhtBIGH3-(RGD)_2蛋白通过上调miR-126表达抑制人脐静脉内皮细胞的生物活性

Biological Activities of HUVECS Is Inhibited by Truncated rhtBIGH3-(RGD)_2 Protein though the Up-regulation of miR-126
原文传递
导出
摘要 目的:探讨miR-126在截短型rhtBIGH3-(RGD)_2蛋白抑制HUVEC细胞生物学活性中的作用。方法:体外培养VEGF孵化的人脐静脉内皮细胞(VEGF-HUVEC),分别加入rhtBIGH3-(RGD)_2蛋白终浓度为0和100μg/mL,作用24、48、72 h条件下,分别检测Caspase-3活性和miR-126表达水平。在rhtBIGH3-(RGD)_2蛋白终浓度为0和100μg/mL时,分别加入miR-126 mimic和miR-126 inhibitor,作用VEGF-HUVEC 48 h后,Real-time PCR检测miR-126表达水平,通过检测Caspase-3活性来检测细胞凋亡情况。结果:在VEGF-HUVEC中,当rhtBIGH3-(RGD)_2蛋白终浓度为100μg/mL条件下,Caspase-3水平升高,miR-126表达水平升高,在48 h下达到最高峰。在VEGF-HUVEC中,当rhtBIGH3-(RGD)_2蛋白终浓度分别为100μg/mL条件下,加入miR-126mimic后,miR-126表达升高,Caspase-3水平升高;加入miR-126 inhibitor后,48 h后检测miR-126表达下降,Caspase-3水平也下降。结论:截短型rhtBIGH3-(RGD)_2蛋白通过上调miR-126表达从而促进细胞凋亡、抑制HUVEC生物活性。 Objective: To explore the effect of truncated rhtBIGH3 protein in inhibiting the biological activities of HUVECS.Methods: Human umbilical vein endothelial cells(HUVECS) were cultured with VEGF in vitro, supplemented with 0 μg/mL and 100μg/mL rhtBIGH3-(RGD)_2 protein. HUVECS were incubated for 24 h, 48 h, 72 h, and testing Caspase-3 activities and miR-126 expression level. Added miR-126 mimic and miR-126 inhibitor when the rhtBIGH3-(RGD)_2 concentration was 0 μg/mL and 100 μg/mL,after 48 h, use Real-time PCR testing the miR-126 expression level, and test the apoptosis though the activity of Caspase-3. Results: In the VEGF-HUVEC supplemented with 100 μg/mL rhtBIGH3-(RGD)_2 protein, the expression of both Caspase-3 and miR-126 raised, and reach the peak at 48 h. In VEGF-HUVEC, when the final concentration of rhtBIGH3-(RGD)_2 protein was 100 μg/mL, after the addition of mimic miR-126, miR-126 and Caspase-3 expression increased, after adding inhibitor 48 h, miR-126 and Caspase-3 expression decreased. Conclusions: The truncated rhtBIGH3-(RGD)_2 protein promote apoptosis and inhibit HUVEC activity by increasing miR-126 expression, thus inhibiting corneal neovascularization.
出处 《现代生物医学进展》 CAS 2017年第2期225-228,共4页 Progress in Modern Biomedicine
基金 黑龙江省教育厅面上项目(12541516) 国家自然科学青年基金项目(81300728)
关键词 rhtBIGH3-(RGD)2蛋白 MIR-126 HUVEC 角膜新生血管 Caspase-3 RhtBIGH3-(RGD)2 protein MiR-126 HUVEC Corneal neovascularization Caspase-3
  • 相关文献

参考文献3

二级参考文献72

  • 1Saloni Agrawal,Brahim Chaqour.MicroRNA signature and function in retinal neovascularization[J].World Journal of Biological Chemistry,2014,5(1):1-11. 被引量:10
  • 2任明华,王淑静,林雪松,徐建永,陶站华,赵炜明,刘兴汉.重组人内皮抑素的结构改造及抗肿瘤活性变化[J].中国生物化学与分子生物学报,2005,21(1):45-52. 被引量:17
  • 3鲍玉洲,张艳敏,李建新.人表皮生长因子真核细胞缓释型滴眼剂的基因治疗研究[J].河南医学研究,2007,16(1):7-11. 被引量:3
  • 4Goldschild M, Bandouin C. Role of integrins in ocular physiology and diseases [ J ]. J Fr Ophthalmol, 1997,20 ( 4 ) : 311 - 325.
  • 5Cbang JH, Gabison EE, Kalo T, et al. Corneal neovascularization [ J ] Curr Opin Ophthalmol,2001,12: 242 - 249.
  • 6Hodivala-Dilke KM ,Reynolds AR, Reynolds LE. lntegrins in angiogenesis multitalented molecules in a balancing act [ J ]. Cell Tissue Res,2003 314(1):131 -144.
  • 7Friedlander M ,Theesfeld CL, Sugita M, et al. Involvement of integrins alphaV beta3 and alphaV beta5 in ocular neovascular diseases[ J]. Proe Natl A cad Scl USA, 1996,93 ( 18 ) : 9764 - 9769.
  • 8Eliceirl BP, Cheresh DA. The role of alphaV integrins during angiogenesis:insights into potential mechanisms of action and clinical development [ J ]. J Clin Invest, 1999,103 (9) : 1227 - 1230.
  • 9Meyer A, Auernheimer J, Mndlinger A, el al. Targeting RGD reeognlzing integrins:drug development, biomaterial researeh, tumor imaging and targeting[ J]. Curt Pharm Des ,2006,12(22) : 2723 - 2747.
  • 10Meerovitch K, Bergeron F, Leblond L, et al. A novel RGD antagonist that targets both alphaV beta 3 and alphaV beta5 induces apoptosis of anglogenie endothelial cells on type collagen [J] .Vascul Pharmacol, 2003,40( 2 ) : 77 - 89.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部